Breast cancer Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. American Society of Anesthesiologists (ASA) physical status I–II 2. Scheduled for unilateral modified radical mastectomy
Exclusion criteria
Exclusion criteria: 1. Obesity 2. Previous breast surgery 3. Bleeding disorders 4. Allergies to study drugs 5. Anticoagulant or chronic analgesic use 6. Severe cardiac, hepatic, or renal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total morphine consumption (mg) measured using the patient-controlled analgesia (PCA) device at 24 hours postoperatively | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Time to first morphine request, recorded from arrival in recovery until the first PCA morphine dose request (minutes) 2. Postoperative pain intensity, measured using the Visual Analog Scale (VAS) at 0, 1, 3, 6, 12, and 24 hours at rest and during movement 3. Quality of Recovery, assessed using the Quality of Recovery-15 (QoR-15) questionnaire at 24 hours postoperatively 4. Incidence of rescue fentanyl administration, based on VAS =4, within the first 24 hours 5. Incidence of postoperative nausea and vomiting (PONV) within 24 hours, recorded as present or absent 6. Patient satisfaction with analgesia, assessed at 24 hours using a 5-point Likert scale | — |
Countries
Türkiye